Neuroone Medical Technologies (NMTC) Receivables (2020 - 2026)

Neuroone Medical Technologies has disclosed Receivables across 7 years of filings, most recently posting $500000.0 for Q1 2026.

• Quarterly Receivables rose 56.85% year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $500000.0 (up 56.85% YoY) and the FY2025 annual result came in at $1.3 million, up 616.05% from the prior year.
• Receivables retreated to $500000.0 in Q1 2026, from $2.7 million in the prior quarter.
• Across five years, Receivables topped out at $2.7 million in Q4 2025 and bottomed at $33237.0 in Q3 2022.
• The 5-year median for Receivables is $410551.0 (2024), against an average of $706129.4.
• The widest YoY moves for Receivables: up 616.05% in 2025, down 42.63% in 2025.
• Neuroone Medical Technologies' Receivables stood at $95319.0 in 2022, then jumped by 470.08% to $543399.0 in 2023, then surged by 335.94% to $2.4 million in 2024, then gained by 12.37% to $2.7 million in 2025, then tumbled by 81.22% to $500000.0 in 2026.
• According to Business Quant data, Receivables over the past three periods registered $500000.0, $2.7 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.